Economics of “Delinking” Are Still Not Good
Delinking would lead to higher costs for patients and taxpayers and put more money in the pockets of brand drug manufacturers.
Delinking would lead to higher costs for patients and taxpayers and put more money in the pockets of brand drug manufacturers.
There has been a flurry of discussion in Washington recently about potential reforms to the child tax credit (CTC).
Next week, Oregon voters will weigh in on a tax-related ballot measure with concerning repercussions.
JD Vance and Kamala Harris have at least one thing in common: proposals to expand the child tax credit (CTC). Currently, the CTC offers households up to $2,000 per child under the age of 17.
During a recent speech at the Detroit Economic Club, former President Donald Trump proposed partially renewing a tax policy in effect prior to the Tax Reform Act of 1986 that allowed taxpayers to fully deduct interest expense on auto loans.